קיוטרן - Qtern
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | A10BD Combinations of oral blood glucose lowering drugs | ||||||
|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||
| צ×רת ××ª× | פ××× - PER OS | ||||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||
| ×ת×××× | Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:- to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control,- when already being treated with the free combination of dapagliflozin and saxagliptin. | ||||||
| |||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× | ||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
Â
|
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ASTRA ZENECA |
| ×©× ××¢× ×ר×ש×× | ASTRAZENECA (ISRAEL) LTD |
| ר×ש××× | ת×ר×× ××ש×: 7/2017. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 10/05/2024 |
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
- ××פ××××פ××××× ×ש×××× ××××× ×§××ר×ת ת×ר×ת ××פ××× ×©× ×¡××רת ×ס×× 2
- ×שפעת ×××פ×× ×¢× ××פ××××פ××××× ×¢× ×××× ×× ×¡×¤×קת ×× ×ס××××× ×ש×ר×ר××ת
- ××××צ×ת ×××ש×ת ×××ª× ××¢××× SGLT2 ××××× ×¡××רת ס×× 1
- ×-FDA ×¤×¨×¡× ××××¨× ×××× ×תר××¤× ×¡×§×¡×××פ××× (××× ×××××) ××××× ×¡××רת ×ס×× 2 ×עק××ת ××§×¨× ××©× ××××
השינוי האחרון נעשה בֹ־9 בדצמבר 2025 ב־17:29